http://www.championsoncology.com
Champions Oncology, Inc. Company Intro
Champions Oncology delivers innovative solutions to oncology research, preclinical drug development, and patient-derived xenografts.
Industry
Healthcare
Champions Oncology, Inc. Headquaters
One University Plaza
Hackensack,07601
United States
Champions Oncology, Inc. Share price
28 Oct 2020 01:25 GMT
$9.09
0.38 (4.36 %)
Champions Oncology, Inc. Market cap
$114.042 M
WMC RANKING
2020
Champions Oncology, Inc. # 105
BiotechnologyLatest Champions Oncology, Inc. News
28 Oct 2020
Humanized Mouse and Rat Model Market analyzes the impact followed by restraints and opportunities and projected developments (2020-2027)
Crown Biosciences (US), Champions Oncology (US), HERA Biolabs (US), Vitalstar Biotechnology (China), Axenis (France), and Harbour Antibodies (China).
28 Oct 2020
Patient Derived Xenograft/PDX Models Market Report, History ...
Crown Bioscience Inc. (US), WuXi AppTec (China), Champions Oncology, Inc. ... EPO Berlin-Buch GmBH (Germany), Shanghai LIDE Biotech Co., Ltd (China), ...
28 Oct 2020
Patient Derived Xenograft Models Market : Industry Trends, Size, Competitive Analysis and Forecast - 2020-2026
Champions Oncology, Inc. (US)Â The Jackson ... Charles River Laboratories International, Inc. (US)Â ... Shanghai LIDE Biotech Co., Ltd (China)Â Xentech ...
WMC Market Score
WMC Market to Revenue Score
Champions Oncology, Inc. Market Financials
Revenue, Expenses, Profit
| Company | Currency | Revenue | Expense | Profit | Market Cap | WMC Sector Score |
| Champions Oncology, Inc. | USD | $34,933 | $17,297 | $-1,259 | $114.042M | 105 |
| Alexion Pharmaceuticals, Inc. | USD | $5,536,800 | $2,523,000 | $846,100 | $26.301B | 1 |
| Vertex Pharmaceuticals Incorporated | USD | $5,402,685 | $2,634,428 | $2,080,775 | $55.268B | 2 |
| 3SBio Inc. | CNY | ¥5,318,091 | ¥3,085,221 | ¥973,717 | ¥19.039B | 3 |
| Incyte Corporation | USD | $2,229,409 | $1,622,822 | $446,906 | $19.322B | 4 |
Market Analytics
Company Search vs Top 4 Industry Competitors
Total Champions Oncology, Inc. Social Followers vs Top 4 Industry Competitors
Champions Oncology, Inc. Post vs Top 4 Industry Competitors
Champions Oncology, Inc. WMC Market Score Calculations
| Details | Revenue | Total Social Followers | Total Social Posts | Search Volume | Digital Footprint Size | Digital change (New Pages) | WMC Market Score |
| Champions Oncology, Inc. | 0.63 | 0.93 | 4.32 | 0 | 0 | 0 | 3.92 |
| Alexion Pharmaceuticals, Inc. | 100 | 13.35 | 100 | 20 | 0 | 0 | 100 |
| Vertex Pharmaceuticals Incorporated | 97.58 | 100 | 4.32 | 26 | 0 | 0 | 97.49 |
| 3SBio Inc. | 96.05 | 0 | 0 | 4 | 0 | 0 | 2.78 |
| Incyte Corporation | 40.27 | 14.27 | 7.19 | 100 | 0 | 0 | 90.87 |
Book a demo
Book a free one-on-one demo with one of our team and see exactly how the WMC business intelligence platform can help you protect and grow revenue.
* required fields
You'll learn how to:
- 1. Automatically monitor your entire digital landscape including competitors
- 2. View all new industry activity in real time
- 3. Monitor your position in your industry
- 4. Enrich your reports and strategy
- 5. Empower your teams with knowledge
